280 related articles for article (PubMed ID: 30498500)
1. Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.
Li L; Zhu H; Zuo X
Front Immunol; 2018; 9():2663. PubMed ID: 30498500
[TBL] [Abstract][Full Text] [Related]
2. IL-33 and the intestine: The good, the bad, and the inflammatory.
Hodzic Z; Schill EM; Bolock AM; Good M
Cytokine; 2017 Dec; 100():1-10. PubMed ID: 28687373
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.
Schwartz C; O'Grady K; Lavelle EC; Fallon PG
Eur J Immunol; 2016 May; 46(5):1091-100. PubMed ID: 27000936
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-33 and Behçet disease: Another cytokine among others.
Hamzaoui K; Bouali E; Hamzaoui A
Hum Immunol; 2015 May; 76(5):301-6. PubMed ID: 25814446
[TBL] [Abstract][Full Text] [Related]
5. The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis.
Xu D; Mu R; Wei X
Front Immunol; 2019; 10():2025. PubMed ID: 31572353
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional analysis of the IL-33 receptor suppression of tumourigenicity 2 and its effects on canine Type 2 T helper cells: a preliminary study.
Asahina R; Nishida H; Kamishina H; Maeda S
Vet Dermatol; 2018 Apr; 29(2):112-e45. PubMed ID: 29178475
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-13 in fibrosis, particularly systemic sclerosis.
O'Reilly S
Biofactors; 2013; 39(6):593-6. PubMed ID: 23893513
[TBL] [Abstract][Full Text] [Related]
8. Unraveling SSc Pathophysiology; The Myofibroblast.
van Caam A; Vonk M; van den Hoogen F; van Lent P; van der Kraan P
Front Immunol; 2018; 9():2452. PubMed ID: 30483246
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic Effects of IL-33 on CD4
Alvarez F; Fritz JH; Piccirillo CA
Front Immunol; 2019; 10():522. PubMed ID: 30949175
[TBL] [Abstract][Full Text] [Related]
10. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
Hong J; Kim S; Lin PC
J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
[TBL] [Abstract][Full Text] [Related]
12. The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine.
Fournié JJ; Poupot M
Front Immunol; 2018; 9():2506. PubMed ID: 30416507
[TBL] [Abstract][Full Text] [Related]
13. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
Lott JM; Sumpter TL; Turnquist HR
J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13.
Aliprantis AO; Wang J; Fathman JW; Lemaire R; Dorfman DM; Lafyatis R; Glimcher LH
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2827-30. PubMed ID: 17307869
[TBL] [Abstract][Full Text] [Related]
15. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases.
Vocca L; Di Sano C; Uasuf CG; Sala A; Riccobono L; Gangemi S; Albano GD; Bonanno A; Gagliardo R; Profita M
Immunobiology; 2015 Aug; 220(8):954-63. PubMed ID: 25747940
[TBL] [Abstract][Full Text] [Related]
16. Involvement of IL-33 in the Pathophysiology of Systemic Lupus Erythematosus: Review.
Sarrand J; Soyfoo M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328556
[TBL] [Abstract][Full Text] [Related]
17. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
Zeng S; Wu J; Liu J; Qi F; Liu B
Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
[TBL] [Abstract][Full Text] [Related]
18. Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury.
Chen WY; Li LC; Wu YH; Yang JL; Tzeng HT
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102434
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin 13 and interleukin 13 receptor involvement in systemic sclerosis].
Granel B; Chevillard C; Dessein A
Rev Med Interne; 2007 Sep; 28(9):613-22. PubMed ID: 17543424
[TBL] [Abstract][Full Text] [Related]
20. Role of IL-33 in inflammation and disease.
Miller AM
J Inflamm (Lond); 2011 Aug; 8(1):22. PubMed ID: 21871091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
